These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27079313)

  • 1. Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus-positive blood donors.
    Fearon M; Scalia V; Lane D; Bigham M; Hawes G; O'Brien S; Kadkhoda K
    Transfusion; 2016 Apr; 56(4):994-5. PubMed ID: 27079313
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets.
    Chudy M; Weber-Schehl M; Pichl L; Jork C; Kress J; Heiden M; Funk MB; Nübling CM
    Transfusion; 2012 Feb; 52(2):431-9. PubMed ID: 21810100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing.
    Müller B; Nübling CM; Kress J; Roth WK; De Zolt S; Pichl L
    Transfusion; 2013 Oct; 53(10 Pt 2):2422-30. PubMed ID: 23782012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
    Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
    J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
    Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
    Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
    Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
    Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology.
    Scuracchio PS; Poli MC; Lemos MM; Oliveira Filho AG; Salles NA; Chamone DA; Magri M; Cavalcante NJ; Collela R
    Transfus Med; 2007 Jun; 17(3):200-4. PubMed ID: 17561863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
    Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
    Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retroviruses.
    Sherman MP; Dock NL; Ehrlich GD; Sninsky JJ; Brothers C; Gillsdorf J; Bryz-Gornia V; Poiesz BJ
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):409-14. PubMed ID: 7786586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
    Moiz B; Moatter T; Shaikh U; Adil S; Ali N; Mahar F; Shamsuddin N; Khurshid M
    Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic detection of human immunodeficiency virus (HIV) by nucleic acid amplification test in a frequent platelet donor during the pre-seroconversion period.
    Pondé RA
    Arch Virol; 2011 Nov; 156(11):2085-90. PubMed ID: 21842160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.
    Wesolowski LG; Delaney KP; Hart C; Dawson C; Owen SM; Candal D; Meyer WA; Ethridge SF; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S45-9. PubMed ID: 21995934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
    Grabarczyk P; van Drimmelen H; Kopacz A; Gdowska J; Liszewski G; Piotrowski D; Górska J; Kuśmierczyk J; Candotti D; Lętowska M; Lelie N; Brojer E
    Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.